Skip to content

Structure Therapeutics

US · GPCR #2815 by market cap Listed 2023
16.13 -0.99 -5.78%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

Quant vs Street three independent views, side by side

StockVane factor grade
C+
Momentum strategy signal
Strong Sell
Analyst consensus
Buy

Signals diverge - worth digging into why.

Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.

Analyst consensus 10 analysts

Buy
Avg price target 103.67 +542.7%
Price target rangecurrent 16.13
Low70.00
Avg103.67
High145.00
Buy 100% Hold 0% Sell 0%
Recent ratings (25)
DateFirmAnalystRatingTarget
2026-11-12 H.C. Wainwright -- Buy 70.00
2026-11-10 CCORF -- Buy 107.00
2026-11-10 Piper Sandler -- Buy 93.00
2026-11-10 Stifel -- Buy 90.00
2026-11-10 BMO Capital -- Buy 145.00
2026-09-09 CCORF -- Buy 111.00
2026-09-09 H.C. Wainwright -- Buy 70.00
2026-09-08 LifeSci Capital -- Buy 104.00
2026-09-08 William Blair -- Buy --
2026-09-08 Jefferies -- Buy 125.00
2026-09-08 Clear Street -- Buy 99.00
2026-08-17 J.P. Morgan -- Buy 100.00
2026-08-10 Morgan Stanley -- Buy 126.00
2026-08-10 Citi -- Buy 97.00
2026-08-07 CCORF -- Buy 111.00
2026-08-07 William Blair -- Buy --
2026-08-07 Piper Sandler -- Buy 93.00
2026-08-07 Citizens JMP -- Buy 110.00
2026-08-07 Stifel -- Buy 90.00
2026-08-07 H.C. Wainwright -- Buy 70.00
2026-08-06 LifeSci Capital -- Buy 104.00
2026-08-06 BMO Capital -- Buy 145.00
2026-08-06 Citi -- Buy 97.00
2026-06-11 H.C. Wainwright -- Buy 70.00
2026-06-09 J.P. Morgan -- Buy --

Price target trend monthly average, last 3 years

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

Structure Therapeutics discussion 0 comments

Add a comment